β-talasemia intermedia i minor (pediatria)
Leczenie podtrzymujące
Chelatacja żelaza
Iron out for nontransfused thalassemia. (opens new window)
Źródło: Blood 2012;120(5):928-9.
Indeks: PubMed 22859709
DOI: 10.1182/blood-2012-06-433227
https://www.ncbi.nlm.nih.gov/pubmed/22859709 (opens new window)
Iron overload in β-thalassemia intermedia: an emerging concern. (opens new window)
Źródło: Curr Opin Hematol 2013;20(3):187-92.
Indeks: PubMed 23426199
DOI: 10.1097/MOH.0b013e32835f5a5c
https://www.ncbi.nlm.nih.gov/pubmed/23426199 (opens new window)
Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia. (opens new window)
Źródło: Expert Rev Hematol 2013;6(5):495-509.
Indeks: PubMed 24083402
DOI: 10.1586/17474086.2013.827411
https://www.ncbi.nlm.nih.gov/pubmed/24083402 (opens new window)
Suplementy diety i inne terapie podtrzymujące
Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (opens new window)
Źródło: Indian J Hematol Blood Transfus 2012;28(1):7-9.
Indeks: PubMed 23449336
DOI: 10.1007/s12288-011-0088-9
https://www.ncbi.nlm.nih.gov/pubmed/23449336 (opens new window)
Therapeutic roles of curcumin: lessons learned from clinical trials. (opens new window)
Źródło: AAPS J 2013;15(1):195-218.
Indeks: PubMed 23143785
DOI: 10.1208/s12248-012-9432-8
https://www.ncbi.nlm.nih.gov/pubmed/23143785 (opens new window)
Determining and surveying the role of carnitine and folic acid to decrease fatigue in β-thalassemia minor subjects. (opens new window)
Źródło: Pediatr Hematol Oncol 2013;30(8):742-7.
Indeks: PubMed 23458634
DOI: 10.3109/08880018.2013.771388
https://www.ncbi.nlm.nih.gov/pubmed/23458634 (opens new window)